These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Endoplasmic Reticulum Stress in Pancreatic Neuroendocrine Tumors is Linked to Clinicopathological Parameters and Possible Epigenetic Regulations. Klieser E; Illig R; Státtner S; Primavesi F; Jáger T; Swierczynski S; Kiesslich T; Kemmerling R; Bollmann C; Di Fazio P; Neureiter D Anticancer Res; 2015 Nov; 35(11):6127-36. PubMed ID: 26504039 [TBL] [Abstract][Full Text] [Related]
4. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas. Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284 [TBL] [Abstract][Full Text] [Related]
5. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2. Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells. Wanek J; Gaisberger M; Beyreis M; Mayr C; Helm K; Primavesi F; Jäger T; Di Fazio P; Jakab M; Wagner A; Neureiter D; Kiesslich T Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321986 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors. Villani V; Mahadevan KK; Ligorio M; Fernández-Del Castillo C; Ting DT; Sabbatino F; Zhang I; Vangel M; Ferrone S; Warshaw AL; Lillemoe KD; Wargo J; Deshpande V; Ferrone CR Ann Surg Oncol; 2016 Dec; 23(Suppl 5):609-617. PubMed ID: 27020585 [TBL] [Abstract][Full Text] [Related]
8. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer. Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512 [TBL] [Abstract][Full Text] [Related]
9. Significance of DNA methyltransferase-1 and histone deacetylase-1 in pancreatic cancer. Wang W; Gao J; Man XH; Li ZS; Gong YF Oncol Rep; 2009 Jun; 21(6):1439-47. PubMed ID: 19424621 [TBL] [Abstract][Full Text] [Related]
10. Short article: Evaluation of O6-methylguanine-DNA methyltransferase as a predicting factor of response to temozolomide-based chemotherapy in well-differentiated metastatic pancreatic neuroendocrine tumors. Girot P; Dumars C; Mosnier JF; Muzellec L; Senellart H; Foubert F; Caroli-Bosc FX; Cauchin E; Regenet N; Matysiak-Budnik T; Touchefeu Y Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):826-830. PubMed ID: 28328619 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival. Giaginis C; Damaskos C; Koutsounas I; Zizi-Serbetzoglou A; Tsoukalas N; Patsouris E; Kouraklis G; Theocharis S BMC Gastroenterol; 2015 Oct; 15():148. PubMed ID: 26502922 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Alexandrou P; Sastre-Garau X J Oral Pathol Med; 2011 Oct; 40(9):706-14. PubMed ID: 21457345 [TBL] [Abstract][Full Text] [Related]
13. Expression of histone deacetylases 1, 2 and 3 in histological subtypes of testicular germ cell tumours. Fritzsche FR; Hasler A; Bode PK; Adams H; Seifert HH; Sulser T; Moch H; Barghorn A; Kristiansen G Histol Histopathol; 2011 Dec; 26(12):1555-61. PubMed ID: 21972094 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading. Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC. Quint K; Agaimy A; Di Fazio P; Montalbano R; Steindorf C; Jung R; Hellerbrand C; Hartmann A; Sitter H; Neureiter D; Ocker M Virchows Arch; 2011 Aug; 459(2):129-39. PubMed ID: 21713366 [TBL] [Abstract][Full Text] [Related]
16. CD133 expression in well-differentiated pancreatic neuroendocrine tumors: a potential predictor of progressive clinical courses. Sakai Y; Hong SM; An S; Kim JY; Corbeil D; Karbanová J; Otani K; Fujikura K; Song KB; Kim SC; Akita M; Nanno Y; Toyama H; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y Hum Pathol; 2017 Mar; 61():148-157. PubMed ID: 27864124 [TBL] [Abstract][Full Text] [Related]
17. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin. Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Hasegawa T; Yamao K; Hijioka S; Bhatia V; Mizuno N; Hara K; Imaoka H; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Kinoshita T; Kohsaki T; Nishimori I; Iwasaki S; Saibara T; Hosoda W; Yatabe Y Endoscopy; 2014 Jan; 46(1):32-8. PubMed ID: 24218309 [TBL] [Abstract][Full Text] [Related]
19. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior. Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors. Ozturk Sari S; Taskin OC; Gundogdu G; Yegen G; Onder S; Keskin M; Saglam S; Ozluk Y; Gulluoglu M; Mete O Endocr Pathol; 2016 Jun; 27(2):162-70. PubMed ID: 26936845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]